{"ModuleTitle": "Company Description", "CompanyName": "Biogen Inc.", "Symbol": "BIIB", "Address": "225 BINNEY STREET, CAMBRIDGE, Massachusetts, 02142, United Kingdom", "Phone": "7814642000", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "Biogen is a global biopharmaceutical company focused on discovering, developing\r\nand delivering worldwide innovative therapies for people living with serious\r\nneurological and neurodegenerative diseases as well as related therapeutic\r\nadjacencies. Our core growth areas include multiple sclerosis (MS) and\r\nneuroimmunology; Alzheimer's disease (AD) and dementia; neuromuscular disorders,\r\nincluding spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS);\r\nmovement disorders, including Parkinson's disease; and ophthalmology. We are\r\nalso focused on discovering, developing and delivering worldwide innovative\r\ntherapies in our emerging growth areas of immunology; neurocognitive disorders;\r\nacute neurology; and pain. In addition, we commercialize biosimilars of advanced\r\nbiologics. We support our drug discovery and development efforts through the\r\ncommitment of significant resources to discovery, research and development\r\nprograms and business development opportunities.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f02%2f06%2f0000875045-20-000005.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "Alfred W. Sandrock", "title": "Chief Medical Officer & EVP-Research & Development"}, {"name": "Jeffrey D. Capello", "title": "Chief Financial Officer & Executive Vice President"}, {"name": "Mark Hernon", "title": "Chief Information Officer & Senior Vice President"}, {"name": "Michel Vounatsos", "title": "Chief Executive Officer & Director"}], "Number_of_employees": ["7,300"], "Subsidiaries": ["NO INFO"]}